Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Evidence-based care guideline for anesthesia, analgesia and sedation following arterial switch operation.

BIBLIOGRAPHIC SOURCE(S)

  • Cincinnati Children's Hospital Medical Center. Evidence based care guideline for anesthesia, analgesia and sedation following arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2006 Jan 10. 8 p. [16 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for anesthesia, analgesia and sedation following arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 22. 8 p.

Once the guideline has been in place for four years, the development team reconvenes to explore the continued validity of the guideline. This phase can be initiated at any point that evidence indicates a critical change is needed.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Each recommendation is followed by evidence grades identifying the type of supporting evidence. Definitions of the evidence grades are presented at the end of the "Major Recommendations" field.

Clinical Assessments

  1. It is recommended that hemodynamic stability be maintained as indicated by mean arterial pressure >45, left atrial pressure <15, and urine output >1cc/kg/hr. Physical exam should indicate adequate perfusion.

    Note 1: Continuous monitoring of electrocardiogram (ECG) and arterial blood pressure via an arterial line is recommended (Local Expert Consensus [E]).

    Note 2: Continuous monitoring of left atrial pressure with a transthoracic catheter is recommended (Local Expert Consensus [E]).

  1. It is recommended that adequate pain relief is provided as indicated by behavioral assessment and the absence of otherwise unexplained tachycardia or hypertension.
  2. It is recommended that patient comfort and sedation be maintained as indicated by behavioral assessment. The patient should not be at risk for inadvertent self-removal of lines and/or tubes.

Treatment Recommendations

  1. It is recommended that a fentanyl infusion at 10 micrograms/kg/hr be started on all post-operative arterial switch patients and maintained for at least 6 hours. The infusion should be discontinued if the patient has had no signs or symptoms of low cardiac output (mean arterial pressure <45, urine output <1 cc/kg/hr, persistent base deficit >-4 despite correction with sodium bicarbonate [NaHCO3] or increase in lactate level >0.5 mg/dl/hr) and is therefore considered a good candidate for extubation in the next 24 hours.

    Note 1: A continuous infusion of high-dose fentanyl is maintained to blunt the physiologic stress response that occurs as a consequence of cardiac surgery (Anand, Hansen, & Hickey, 1990 [D]; Anand & Hickey, 1992 [B]). Because cardiac output decreases for at least the first 6 hours following cardiopulmonary bypass, it is recommended that the infusion be continued for at least this length of time (Wernovsky et al., 1995 [A]).

    Note 2: Because of the redistribution of fentanyl into lipid tissue, long-term infusion may result in prolongation of side effects such as apnea well beyond termination of the infusion (Cincinnati Children's Hospital Medical Center Formulary, 2006)[X]. Therefore, once pain management, rather than hemodynamic stability, becomes the primary reason for narcotic use, it is desirable to use bolus dosing of a less lipophilic agent such as morphine and to discontinue the fentanyl infusion (Local Expert Consensus [E]).

    Note 3: Ongoing metabolic acidosis caused by the continued production of lactic acid has been associated with a poor outcome following cardiac surgery in infants and children. (Charpie et al., 2000 [C]; Munoz et al., 2000 [C]).

  1. It is recommended that midazolam (0.1 mg/kg/dose every 1 to 2 hours) or lorazepam (0.1 mg/kg/dose every 6 to 8 hours) be given concurrently with the fentanyl infusion to ensure adequate sedation in addition to anesthesia/analgesia.

    Note: Because of the variability in neonatal response to fentanyl and because of rapid development of tolerance to its sedative effects (in contrast to respiratory depressant effects), additional use of benzodiazepines is often necessary to maintain adequate sedation (Arnold et al., 1991 [C]).

  1. It is recommended that adequate analgesia and sedation be provided using as needed doses of morphine (0.1 mg/kg/dose) and midazolam (0.1 mg/kg/dose) once the fentanyl infusion has been discontinued.

    Note: The longer half-life of morphine makes it a better choice for intermittent dosing than fentanyl. The histamine release associated with morphine should be well tolerated hemodynamically by patients who are otherwise stable 6 hours after cardiopulmonary bypass (Saarenmaa et al., 1999 [A]; Saarenmaa, Neuvonen, & Fellman, 2000 [C]; Santeiro et al., 1997 [C]; Hamon et al., 1996 [C]; Katz & Kelly, 1993 [C]; Arnold et al., 1991 [C]; Murat et al., 1988 [C]).

Definitions:

Evidence Based Grading Scale

M: Meta-analysis or systematic review
A: Randomized controlled trial: large sample
B: Randomized controlled trial: small sample
C: Prospective trial or large case series
D: Retrospective analysis
S: Review article
O: Other evidence
E: Expert opinion or consensus
F: Basic laboratory research
L: Legal requirement
Q: Decision analysis
X: No evidence

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

REFERENCES SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence is identified and classified for each recommendation (see "Major Recommendations") using the following scheme:

M: Meta-analysis or systematic review
A: Randomized controlled trial: large sample
B: Randomized controlled trial: small sample
C: Prospective trial or large case series
D: Retrospective analysis
S: Review article
O: Other evidence
E: Expert opinion or consensus
F: Basic laboratory research
L: Legal requirement
Q: Decision analysis
X: No evidence

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Cincinnati Children's Hospital Medical Center. Evidence based care guideline for anesthesia, analgesia and sedation following arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2006 Jan 10. 8 p. [16 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2001 Jan 22 (revised 2006 Jan 1)

GUIDELINE DEVELOPER(S)

Cincinnati Children's Hospital Medical Center - Hospital/Medical Center

SOURCE(S) OF FUNDING

Cincinnati Children's Hospital Medical Center

GUIDELINE COMMITTEE

Cardiac Guideline Development Team 2006

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Cincinnati Children's Hospital Medical Center Physicians: Peter Manning , MD, Cardiac Surgery; Catherine Dent, MD, Cardiac Intensive Care; William Border, MD, Cardiology; James Spaeth MD, Anesthesia; Michael Alice Moga, MD, Cardiology/Fellow

Patient Services: Karen Uzark, PhD, CPNP, Cardiology; Susan Ryckman, MS, CPNP, Cardiac Services; Betsy Adler, MS, PNP, Cardiac Surgery; Melissa Magness, RN, Cardiac ICU; Tammy Lingsch, RN, A6 Central; Cynthia Wedekind, Pharm D, Clinical Pharmacy; Jenni Raake, RRT, Respiratory Care; Shawna Kirkendall, RN, Manager, A 6 Central

Division of Health Policy & Clinical Effectiveness Support: Eloise Clark, MPH; Danette Stanko, MA, MPH, Epidemiologist; Kate Rich, Lead Decision Support Analyst; Carol Frese, RN, Medical Reviewer; Eduardo Mendez, RN, MPH, Dir. Evidence-Based Care; Edward Donovan, MD, Medical Director, Clinical Effectiveness

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

This guideline was developed without external funding.

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for anesthesia, analgesia and sedation following arterial switch operation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 22. 8 p.

Once the guideline has been in place for four years, the development team reconvenes to explore the continued validity of the guideline. This phase can be initiated at any point that evidence indicates a critical change is needed.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the Cincinnati Children's Hospital Medical Center Web site.

For information regarding the full-text guideline, print copies, or evidence based practice support services contact the Children's Hospital Medical Center Health Policy and Clinical Effectiveness Department at HPCEInfo@chmcc.org.

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

The following is available:

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI on March 11, 2004. This NGC summary was updated by ECRI on November 29, 2006. The updated information was verified by the guideline developer on December 19, 2006.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

Copies of Cincinnati Children's Hospital Medical Center (CCHMC) Evidence-Based Clinical Practice Guidelines (EBCG) are available online and may be distributed by any organization for the global purpose of improving child health outcomes. Examples of approved uses of CCHMC´s EBCG include the following:

  • Copies may be provided to anyone involved in the organization's process for developing and implementing evidence-based care guidelines.
  • Hyperlinks to the CCHMC website may be placed on the organization's website.
  • The EBCG may be adopted or adapted for use within the organization, provided that CCHMC receives appropriate attribution on all written or electronic documents.
  • Copies may be provided to patients and the clinicians who manage their care.

Notification of CCHMC at HPCEInfo@cchmc.org for any EBCG adopted, adapted, implemented or hyperlinked to by a given organization and/or user, is appreciated.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo